Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
International Journal of Molecular Sciences · 14.02.2023 · 24 (4) · 3841
DOI: 10.3390/ijms24043841 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2023. Verfasst von Zhenqi Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Logistics Research Program, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most frequent cause of cognitive impairment in middle-aged and older populations. There is a lack of drugs that demonstrate significant efficacy in AD, so the study of the pathogenesis of AD is of great importance. More efficacious interventions are needed, as reflected by our population’s fast aging. Synaptic plasticity is the capacity of neurons to adjust their connections, and it is strongly tied to learning and memory, cognitive function, and brain injury recovery. Changes in synaptic strength, such as long-term potentiation (LTP) or inhibition (LTD), are thought to represent the biological foundation of the early stages of learning and memory. The results of numerous studies confirm that neurotransmitters and their receptors play an important role in the regulation of synaptic plasticity. However, so far, there is no definite correlation between the function of neurotransmitters in aberrant neural oscillation and AD-related cognitive impairment. We summarized the AD process to understand the impact of neurotransmitters in the progression and pathogenesis of AD, including the current status of neurotransmitter target drugs, and the latest evidence of neurotransmitters’ function and changes in the AD process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, China.
Förderung
- Logistics Research Program
- National Natural Science Foundation of China
Zitieren
APA
Yang, Z., Zou, Y., & Wang, L. (2023). Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 24(4), 3841. https://doi.org/10.3390/ijms24043841
Vancouver
Yang Z, Zou Y, Wang L. Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(4):3841. doi:10.3390/ijms24043841
BibTeX
@article{Yang2023,
author = {Yang, Zhenqi and Zou, Yong and Wang, Lifeng},
title = {Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3841},
doi = {10.3390/ijms24043841}
}
EUVIMED